REVIVA PHARMACEUTICALS HOLDI (RVPH)

US76152G1004 - Common Stock

2.99  +0.01 (+0.34%)

After market: 2.97 -0.02 (-0.67%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-2-29)
2019
(2019-2-28)
Revenue
0.000.000.000.000.00
Operating Expenses
37.29M24.31M10.10M720.00K150.00K
Research and Development
29.25M18.95M4.85M300.00KN/A
Selling, General, and Administrative Expenses
8.05M5.36M5.25M2.14MN/A
Operating Income
-37.29M-24.31M-10.10M-720.00K-150.00K
Interest Income/Expense
445.86K180.00K0.001.34M730.00K
Other Income/Expense
-775.73K-190.00K1.59MN/AN/A
Income Before Taxes
-37.63M-24.32M-8.52M620.00K570.00K
Income Tax
32.12K20.00K10.00K0.00N/A
Net Income
-37.65M-24.34M-8.52M620.00K570.00K
 
Per Share Data
EPS Diluted Total Ops
-1.66-1.25-0.580.240.28
Non GAAP EPS
-1.67-1.25-0.56N/AN/A
 
Statistics

All data in USD

Charts